OTCQB
AXIM

Axim Biotechnologies Inc

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

Axim Biotechnologies Inc Stock Price

Vitals

Today's Low:
$0.0221
Today's High:
$0.0261
Open Price:
$0.0261
52W Low:
$0.016
52W High:
$0.125
Prev. Close:
$0.024
Volume:
1262112

Company Statistics

Market Cap.:
$6.02 million
Book Value:
-0.028
Revenue TTM:
$16272
Operating Margin TTM:
-25998.35%
Gross Profit TTM:
$8875
Profit Margin:
0%
Return on Assets TTM:
-58.06%
Return on Equity TTM:
-10019.09%

Company Profile

Axim Biotechnologies Inc had its IPO on under the ticker symbol AXIM.

The company operates in the Healthcare sector and Biotechnology industry. Axim Biotechnologies Inc has a staff strength of 6 employees.

Stock update

Shares of Axim Biotechnologies Inc opened at $0.03 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.03, and closed at $0.03.

This is a +7.08% increase from the previous day's closing price.

A total volume of 1,262,112 shares were traded at the close of the day’s session.

In the last one week, shares of Axim Biotechnologies Inc have increased by +11.74%.

Axim Biotechnologies Inc's Key Ratios

Axim Biotechnologies Inc has a market cap of $6.02 million, indicating a price to book ratio of 2.8584 and a price to sales ratio of 943.933.

In the last 12-months Axim Biotechnologies Inc’s revenue was $16272 with a gross profit of $8875 and an EBITDA of $-3804097. The EBITDA ratio measures Axim Biotechnologies Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Axim Biotechnologies Inc’s operating margin was -25998.35% while its return on assets stood at -58.06% with a return of equity of -10019.09%.

In Q1, Axim Biotechnologies Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 57.2%.

Axim Biotechnologies Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Axim Biotechnologies Inc’s profitability.

Axim Biotechnologies Inc stock is trading at a EV to sales ratio of 2221.8522 and a EV to EBITDA ratio of -1.3009. Its price to sales ratio in the trailing 12-months stood at 943.933.

Axim Biotechnologies Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$4.04 million
Total Liabilities
$4.86 million
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Axim Biotechnologies Inc ended 2024 with $4.04 million in total assets and $0 in total liabilities. Its intangible assets were valued at $4.04 million while shareholder equity stood at $-6161264.00.

Axim Biotechnologies Inc ended 2024 with $0 in deferred long-term liabilities, $4.86 million in other current liabilities, in common stock, $-66887804.00 in retained earnings and $0 in goodwill. Its cash balance stood at $53542.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $5.34 million.

Axim Biotechnologies Inc’s total current assets stands at $56556.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.18 million and inventory worth $0.

In 2024, Axim Biotechnologies Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Axim Biotechnologies Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.03
52-Week High
$0.125
52-Week Low
$0.016
Analyst Target Price
$

Axim Biotechnologies Inc stock is currently trading at $0.03 per share. It touched a 52-week high of $0.125 and a 52-week low of $0.125. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.03 and 200-day moving average was $0.03 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 3333.9% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Axim Biotechnologies Inc

The stock symbol (also called stock or share ticker) of Axim Biotechnologies Inc is AXIM

The IPO of Axim Biotechnologies Inc took place on

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
Redington Ltd (REDINGTON)
$160.25
-4.9
-2.97%
$2.75
0.06
+2.23%
$16.8
0.57
+3.51%
BRP Inc (DOOO)
$75
1.34
+1.82%
$5204.1
-38.7
-0.74%
$33.61
-0.4
-1.18%
$24.05
-0.49
-2%
$2.6
-0.01
-0.38%
$29
0.08
+0.28%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It is also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

Address

6191 Cornerstone Court, East, San Diego, CA, United States, 92121